» Articles » PMID: 19541912

Profiling the T-cell Receptor Beta-chain Repertoire by Massively Parallel Sequencing

Overview
Journal Genome Res
Specialty Genetics
Date 2009 Jun 23
PMID 19541912
Citations 214
Authors
Affiliations
Soon will be listed here.
Abstract

T-cell receptor (TCR) genomic loci undergo somatic V(D)J recombination, plus the addition/subtraction of nontemplated bases at recombination junctions, in order to generate the repertoire of structurally diverse T cells necessary for antigen recognition. TCR beta subunits can be unambiguously identified by their hypervariable CDR3 (Complement Determining Region 3) sequence. This is the site of V(D)J recombination encoding the principal site of antigen contact. The complexity and dynamics of the T-cell repertoire remain unknown because the potential repertoire size has made conventional sequence analysis intractable. Here, we use 5'-RACE, Illumina sequencing, and a novel short read assembly strategy to sample CDR3(beta) diversity in human T lymphocytes from peripheral blood. Assembly of 40.5 million short reads identified 33,664 distinct TCR(beta) clonotypes and provides precise measurements of CDR3(beta) length diversity, usage of nontemplated bases, sequence convergence, and preferences for TRBV (T-cell receptor beta variable gene) and TRBJ (T-cell receptor beta joining gene) gene usage and pairing. CDR3 length between conserved residues of TRBV and TRBJ ranged from 21 to 81 nucleotides (nt). TRBV gene usage ranged from 0.01% for TRBV17 to 24.6% for TRBV20-1. TRBJ gene usage ranged from 1.6% for TRBJ2-6 to 17.2% for TRBJ2-1. We identified 1573 examples of convergence where the same amino acid translation was specified by distinct CDR3(beta) nucleotide sequences. Direct sequence-based immunoprofiling will likely prove to be a useful tool for understanding repertoire dynamics in response to immune challenge, without a priori knowledge of antigen.

Citing Articles

Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical Overview.

Belardi R, Pacifici F, Baldetti M, Velocci S, Minieri M, Pieri M Int J Mol Sci. 2025; 26(5).

PMID: 40076585 PMC: 11900248. DOI: 10.3390/ijms26051960.


Editorial: Methods in alloimmunity and transplantation: 2023.

Moll G, Beilhack A Front Immunol. 2024; 15:1516554.

PMID: 39588366 PMC: 11586340. DOI: 10.3389/fimmu.2024.1516554.


A Comprehensive Analysis of the Genomic and Expressed Repertoire of the T-Cell Receptor Beta Chain in .

Antonacci R, Giannico F, Moschetti R, Pala A, Caputi Jambrenghi A, Massari S Animals (Basel). 2024; 14(19).

PMID: 39409766 PMC: 11475548. DOI: 10.3390/ani14192817.


Full-length single-cell BCR sequencing paired with RNA sequencing reveals convergent responses to pneumococcal vaccination.

Morgan D, Zhang Y, Kim J, Murillo M, Singh S, Loschko J Commun Biol. 2024; 7(1):1208.

PMID: 39341987 PMC: 11438910. DOI: 10.1038/s42003-024-06823-0.


The reverse TRBV30 gene of mammals: a defect or superiority in evolution?.

Wu F, Wu Y, Yao Y, Xu Y, Peng Q, Ma L BMC Genomics. 2024; 25(1):705.

PMID: 39030501 PMC: 11264764. DOI: 10.1186/s12864-024-10632-4.


References
1.
Gellert M . V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem. 2002; 71:101-32. DOI: 10.1146/annurev.biochem.71.090501.150203. View

2.
Davis M, Bjorkman P . T-cell antigen receptor genes and T-cell recognition. Nature. 1988; 334(6181):395-402. DOI: 10.1038/334395a0. View

3.
Krangel M . Gene segment selection in V(D)J recombination: accessibility and beyond. Nat Immunol. 2003; 4(7):624-30. DOI: 10.1038/ni0703-624. View

4.
Hall M, Lanchbury J . Healthy human T-cell receptor beta-chain repertoire. Quantitative analysis and evidence for J beta-related effects on CDR3 structure and diversity. Hum Immunol. 1995; 43(3):207-18. DOI: 10.1016/0198-8859(95)00013-t. View

5.
Even J, Lim A, Puisieux I, Ferradini L, Dietrich P, Toubert A . T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res Immunol. 1995; 146(2):65-80. DOI: 10.1016/0923-2494(96)80240-9. View